Salbutamol-induced Decrease in Augmentation Index is Related to the Parallel Increase in Heart Rate

Area of Science:

• Cardiovascular Physiology
• Pharmacodynamics
• Vascular Biology

Background:

• Augmentation index (AI) changes after salbutamol inhalation are used to assess endothelial function.
• The influence of salbutamol-induced heart rate increase on AI requires further investigation.
• Understanding hemodynamic responses to bronchodilators is crucial for accurate physiological assessments.

Purpose of the Study:

• To determine the contribution of salbutamol-induced heart rate increase to the observed decrease in augmentation index.
• To differentiate the hemodynamic effects of salbutamol from an endothelium-independent agent (nitroglycerin).
• To evaluate the validity of using AI changes post-salbutamol as a marker of endothelial function.

Main Methods:

• Whole-body impedance cardiography and continuous pulse wave analysis were used to record hemodynamic parameters.
• 335 subjects without cardiovascular medications underwent passive head-up tilt.
• Effects of salbutamol inhalation (0.4 mg) and sublingual nitroglycerin (0.25 mg) on AI were compared in supine and upright positions.

Main Results:

• Salbutamol decreased augmentation index by ~3-4% units, with significant explanatory factors being increased heart rate and decreased ejection duration.
• Nitroglycerin decreased augmentation index by ~15-23% units, with increased heart rate, reduced ejection duration, and reduced systemic vascular resistance as explanatory factors.
• Salbutamol moderately increased cardiac index (+4.5%) and decreased systemic vascular resistance (-8.5%).

Conclusions:

• The decrease in augmentation index following salbutamol inhalation is largely attributable to an increased heart rate.
• This suggests that the observed AI reduction with salbutamol may not predominantly reflect endothelial function.
• Careful consideration of heart rate effects is necessary when interpreting AI changes after salbutamol administration.